Pages that link to "Q41590860"
Jump to navigation
Jump to search
The following pages link to Jerome Ritz (Q41590860):
Displayed 50 items.
- ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction (Q24531314) (← links)
- Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation (Q24537575) (← links)
- Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission (Q24539030) (← links)
- Evidence against T-cell development in the adult human intestinal mucosa based upon lack of terminal deoxynucleotidyltransferase expression (Q24541454) (← links)
- Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia (Q24604091) (← links)
- Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol (Q24655823) (← links)
- Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor (Q24670205) (← links)
- Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis (Q24673367) (← links)
- B cells in chronic graft-versus-host disease (Q26861706) (← links)
- Reprint of: B cells in chronic graft-versus-host disease (Q27030747) (← links)
- The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease (Q28076264) (← links)
- Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors (Q28201493) (← links)
- Activation of a novel human transforming gene, ret, by DNA rearrangement (Q28286635) (← links)
- Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation (Q28299225) (← links)
- Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target (Q28306608) (← links)
- Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation (Q30277751) (← links)
- Probing circulating tumor cells in microfluidics (Q30440019) (← links)
- CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia (Q30679410) (← links)
- CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells. (Q30859024) (← links)
- Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens (Q31013050) (← links)
- CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells (Q31883565) (← links)
- Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature (Q33351942) (← links)
- Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission (Q33380959) (← links)
- Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction (Q33384384) (← links)
- Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells (Q33526746) (← links)
- Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease (Q33583414) (← links)
- Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia (Q33591867) (← links)
- White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcome (Q33650918) (← links)
- Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes (Q33709766) (← links)
- Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens. (Q33779931) (← links)
- Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans (Q33781179) (← links)
- An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition (Q33798102) (← links)
- Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. (Q33815631) (← links)
- Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age (Q33838116) (← links)
- MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells (Q33847322) (← links)
- Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults. (Q33847973) (← links)
- Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion (Q33857800) (← links)
- Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia (Q33917224) (← links)
- Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors (Q34079116) (← links)
- High levels of B-cell activating factor in patients with active chronic graft-versus-host disease (Q34135089) (← links)
- Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation (Q34156279) (← links)
- Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation (Q34180880) (← links)
- Time to put the CAR-T before the horse. (Q34230116) (← links)
- Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure (Q34264469) (← links)
- Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells (Q34298729) (← links)
- Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors (Q34312702) (← links)
- Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. (Q34354733) (← links)
- Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation (Q34396189) (← links)
- Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis. (Q34451427) (← links)
- Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. (Q34548829) (← links)